摘要
目的探究依那普利联合丹参川芎嗪对脑血栓患者的影响。方法 2013年1月—2015年11月选取该院91例老年脑血栓患者随机分为2组,对照组采用右旋糖酐+丹参川芎嗪治疗,观察组在对照组的前提下加用依那普利治疗。结果观察组的总有效率高于对照组(95.83%VS69.76%);观察组治疗后血浆超氧化物岐化酶与内皮素-1改善程度优于对照组差异有统计学意义(P<0.05)。结论依那普利联合丹参川芎嗪对脑血栓患者的治疗效果显著,可改善血浆超氧化物岐化酶与内皮素水平。
Objective To explore the enalaprilat joint salvia miltiorrhiza ligustrazine effect on the patients with cerebral thrombosis. Methods Select 91 cases of elderly patients with cerebral thrombosis was divided into 2 groups in January2013-November 2015,control group using dextran plus salvia miltiorrhiza ligustrazine therapy, observation group under the premise of in the control group treated with enalaprilat. Results The total effective rate was higher than the control group（95.83% VS69.76%）; Observation group after treatment serum superoxide disproportionation enzyme and improve the degree of endothelin- 1 is better than that of control group（P〈0.05）. Conclusion Enalaprilat joint salvia miltiorrhiza ligustrazine on the treatment of patients with cerebral thrombosis effect significantly, can improve the plasma superoxide disproportionation enzyme and endothelin level.
出处
《系统医学》
2016年第5期24-25,28,共3页
Systems Medicine
关键词
依那普利
丹参川芎嗪
老年脑血栓
Enalaprilat
Salvia miltiorrhiza ligustrazine
Elderly cerebral thrombus
